EMP1

EMP1, also known as endothelin-converting enzyme 1, is a metalloproteinase enzyme. It plays a crucial role in the biosynthesis of endothelin peptides. Endothelin peptides are potent vasoconstrictors, meaning they narrow blood vessels. EMP1 is a type of ectoenzyme, suggesting it functions on the surface of cells.

The primary function of EMP1 is to cleave a precursor peptide called big endothelin. This cleavage converts big endothelin into its biologically active form, endothelin-1. Endothelin-1 then binds to specific receptors on smooth muscle cells, leading to vasoconstriction and an increase in blood pressure. This system is important for regulating blood pressure and maintaining cardiovascular homeostasis.

Beyond its role in blood pressure regulation, EMP1 and endothelin signaling are implicated in various physiological and pathological processes. These include cell growth, proliferation, inflammation, and fibrosis. Consequently, EMP1 has become a target for therapeutic intervention in conditions such as hypertension, pulmonary arterial hypertension, and certain types of cancer where dysregulated endothelin signaling is observed. Research continues to explore the multifaceted roles of EMP1 in health and disease.